The polymorphisms rs5743708 for the TLR2 and the rs187084_rs5743836 TLR9 haplotypes appear to be involved in the development of clinical forms of PsA and can be a possible therapeutic target for the rheumatic diseases. The gene discussed is TLR9; the disease is rheumatic disorder.